Keyphrases
Cisplatin
100%
Intratumoral Injection
100%
Patency
100%
Central Airways
100%
Endobronchial Tumor
100%
Endobronchial
60%
Bronchoscopic
60%
Malignant Airway Obstruction
60%
Overall Survival
40%
Airway Obstruction
40%
Performance Status
40%
Treatment Cycle
40%
Histology
20%
Treatment Response
20%
Etiology
20%
Lung Cancer
20%
Comparative Effectiveness Studies
20%
Non-responders
20%
Quality of Life
20%
Systemic Therapy
20%
Adenocarcinoma
20%
Tumor Response
20%
Patient Characteristics
20%
Retrospective Analysis
20%
Squamous Cell Carcinoma (SqCC)
20%
Adverse Events
20%
Life Expectancy
20%
Sodium Chloride
20%
Therapeutic Outcome
20%
Primary Outcome Measure
20%
Malignant Tumor
20%
Relative Reduction
20%
Small Cell Carcinoma
20%
Number of Treatment
20%
Ablative
20%
Treatment Side Effects
20%
Tumor Histology
20%
Cycle Performance
20%
Safety Effectiveness
20%
Malignant Obstruction
20%
Procedural Method
20%
Single-center Retrospective Study
20%
Treatment Modalities
20%
Palliative Treatment
20%
Treatment Session
20%
Large Cell Undifferentiated Carcinoma
20%
Medicine and Dentistry
Airway Obstruction
100%
Intratumoral Drug Administration
100%
Bronchus Tumor
100%
Cisplatin
100%
Malignant Neoplasm
40%
Obstruction
40%
Overall Survival
40%
Quality of Life
20%
Lung Cancer
20%
Neoplasm
20%
Adverse Event
20%
Squamous Cell Carcinoma
20%
Adenocarcinoma
20%
Effectiveness Study
20%
Treatment Response
20%
Patient Characteristics
20%
Systemic Therapy
20%
Retrospective Study
20%
Life Expectancy
20%
Large Cell
20%
Small-Cell Carcinoma
20%
Symptomatic Treatment
20%
Anaplastic Carcinoma
20%
Tumor Histology
20%
Intraluminal Drug Administration
20%
Treatment Modality
20%
Primary Outcome
20%
Side Effect
20%
Pharmacology, Toxicology and Pharmaceutical Science
Cisplatin
100%
Bronchus Tumor
100%
Airway Obstruction
100%
Malignant Neoplasm
40%
Obstruction
40%
Overall Survival
40%
Neoplasm
40%
Retrospective Study
20%
Effectiveness Study
20%
Lung Cancer
20%
Squamous Cell Carcinoma
20%
Adverse Event
20%
Life Expectancy
20%
Small Cell Carcinoma
20%
Adenocarcinoma
20%
Anaplastic Carcinoma
20%
Side Effect
20%